2021 Annual Meeting Knee Access Pass-Subchondroplasty: Phasing out or here to stay?

Subchondroplasty: Phasing out or here to stay?

Video Transcription

Video Summary

The discussion focuses on bone marrow lesions (BMLs) in osteoarthritis (OA), highlighting their role in cartilage loss, pain, and increased risk of total knee arthroplasty (TKA). Calcium phosphate subchondroplasty shows promise by providing structural support and reducing inflammation, delaying or improving symptoms in moderate to severe OA patients. Clinical studies reveal pain relief and functional improvements, though results vary and randomized trials are lacking. Emerging biologic treatments like platelet-rich plasma (PRP) and bone marrow aspirate concentrate (BMAC) exhibit early success in pain reduction and delaying TKA. More high-quality research is needed to identify optimal candidates and improve outcomes.

Asset Caption

Dr. David Flanigan | Osteoarthritis and the Aging Athlete

Keywords

bone marrow lesions

osteoarthritis

calcium phosphate subchondroplasty

platelet-rich plasma

total knee arthroplasty